What does positive surgical margins mean for Stomach Cancer
For informational purposes only
This answer was generated by AI grounded in NCCN guidelines and published medical literature. It is not medical advice. Always consult your oncologist or care team before making treatment decisions.
Understanding Positive Surgical Margins in Stomach Cancer
What "Positive Margins" Means
When your pathology report mentions positive surgical margins, it means that cancer cells were found at the edge of the tissue that was removed during surgery. In other words, the surgeon couldn't get completely around the tumor with a border of healthy tissue—the cancer extends right to where the surgeon had to stop cutting.
Think of it like this: imagine trying to cut out a stain from fabric. A negative margin means you cut out the stain plus a clean ring of unstained fabric around it. A positive margin means the stain goes all the way to the edge of what you cut out.
Why Margins Matter for Stomach Cancer
According to NCCN Guidelines for Gastric Cancer, surgical margin status is a critical factor in treatment planning. The goal of stomach cancer surgery is to remove:
- The tumor itself
- A surrounding border of healthy stomach tissue
- Nearby lymph nodes that may contain cancer
Positive margins indicate that:
- Some cancer cells may have been left behind in the stomach
- There's a higher risk that the cancer could grow back locally (in the same area)
- Additional treatment may be needed to address any remaining disease
What Happens Next After Positive Margins
Your oncology team will typically consider several options:
1. Re-resection (Second Surgery)
- Sometimes surgeons can perform another operation to remove more tissue and achieve negative margins
- This is preferred when it's technically possible and won't cause excessive harm to your health
2. Additional Systemic Therapy
- Chemotherapy may be recommended to target any microscopic cancer cells that may remain
- According to NCCN Guidelines, systemic therapy is often considered for patients with positive margins to reduce the risk of recurrence
3. Radiation Therapy
- In some cases, radiation may be used to treat the surgical bed (the area where the tumor was removed)
- This is less commonly used for gastric cancer than for some other cancers, but your doctor may discuss it
4. Enhanced Surveillance
- More frequent imaging and endoscopy (camera down the throat) to monitor for any signs of recurrence
Questions to Ask Your Oncologist
Since positive margins require individualized decision-making, here are important questions for your care team:
-
"How extensive are the positive margins—are cancer cells right at the edge, or is there a larger area involved?"
-
"Is re-resection (another surgery) an option for my specific case, and what would be the benefits and risks?"
-
"What systemic therapy (chemotherapy) do you recommend, and how long would treatment last?"
-
"Will I need radiation therapy, and if so, what would that involve?"
-
"How will you monitor me after treatment to catch any recurrence early?"
-
"What is my prognosis with this finding, and how does treatment affect my outlook?"
Important Context
Positive margins are a serious finding, but they don't mean your cancer is untreatable. Many patients with positive margins go on to have good outcomes with appropriate multimodal treatment (surgery combined with chemotherapy and/or radiation). The key is working closely with your multidisciplinary team—surgeons, medical oncologists, and radiation oncologists—to develop a comprehensive treatment plan tailored to your specific situation.
Your oncologist will determine the most appropriate approach for YOUR case based on the complete clinical picture, including the extent of the positive margins, your overall health, and other factors specific to your cancer.
This information is for educational purposes only. Always consult your healthcare team for personalized medical advice and decisions.
This is general information.
Upload your records for guidance specific to YOUR diagnosis — personalized to your biomarkers, stage, and treatment history.
Source Guidelines
NCCN Guidelines for Patients: Gastric Cancer (2026)Browse all NCCN Guidelines for Patients →Get guidance specific to your case
This answer covers general information. For guidance based on YOUR records, biomarkers, and treatment history: